← Back to headlines
Beam Therapeutics Reports GAAP EPS of $2.33 and Revenue of $114.1M
Beam Therapeutics announced its GAAP EPS at $2.33 and reported revenue of $114.1 million, providing an update on its financial performance.
24 Feb, 12:27 — 24 Feb, 12:27
Sources
Showing 1 of 1 sources
Related Stories
Elon Musk Condemns New Documentary as 'Hit Piece' and Threatens Legal Action
42m ago
UAE Announces $46 Billion Investment Plan to Strengthen Economic Ties with Germany
44m ago
TTM Technologies Prices $500 Million Senior Notes
1h ago
Adobe Beats Q3 Revenue Estimates Despite Wall Street Demand for More AI Growth
1h ago